AlphAIalphai — Financial news for AI agents
StockNASDAQ · US · USDHealthcare · Drug Manufacturers - Specialty & Generic

$RDHL

RedHill Biopharma Ltd.

Insider trades
Price · $RDHLvia TradingView
AI sentiment · 7d0 articles

No enriched coverage for $RDHL in the last 7 days.

Insider · 30dAll trades →
Buys
—
0 txs
Sells
$1K
1 txs
Raday Gilead1× · $1K
10b5-1 plan0%
See all $RDHL insider activity →
Top stories · $RDHLMore →
JAN 1·TipRanksMed

RedHill Biopharma Files Pro Forma Financials After Talicia Joint Venture Deal With Cumberland

RedHill Biopharma completed a joint venture with Cumberland Pharmaceuticals on October 17, 2025, by selling a 30% equity stake in Talicia Holdings Inc. This deal involved Cumberland investing $4 million for joint control of THI, leading RedHill to deconsolidate THI operations and classify them as discontinued. RedHill has since filed unaudited pro forma financials to show the impact of this new financial structure and joint venture accounting on its historical results.

See more news on $RDHL →

RDHL sentiment & insider activity

In the last 30 days, RDHL insiders filed 1 SEC Form 4 transaction — no purchases and 1 sale ($1K). The most active reporter was Raday Gilead, Chief Operating Officer, with 1 filing.

What's driving RDHL

  • RedHill Biopharma's joint venture with Cumberland and subsequent financial reporting adjustments have led to a somewhat bearish sentiment, with a negative impact on stock valuation.

    TipRanks · Jan 1, 2026

alphai scores every news story that mentions RDHL with an AI model for sentiment and relevance, and aggregates insider trades from RedHill Biopharma Ltd.'s SEC EDGAR Form 4 filings. Figures refresh continuously.

News on $RDHL

Score
JAN 1$RDHLMedTipRanks

RedHill Biopharma Files Pro Forma Financials After Talicia Joint Venture Deal With Cumberland

RedHill Biopharma completed a joint venture with Cumberland Pharmaceuticals on October 17, 2025, by selling a 30% equity stake in Talicia Holdings Inc. This deal involved Cumberland investing $4 million for joint control of THI, leading RedHill to deconsolidate THI operations and classify them as discontinued. RedHill has since filed unaudited pro forma financials to show the impact of this new financial structure and joint venture accounting on its historical results.

3 min read

Related tickers

More in Drug Manufacturers - Specialty & Generic